BACKGROUND: Gay, bisexual, and other men who have sex with men (MSM) are at high risk for human papillomavirus (HPV) infection; vaccination is recommended for US males, including MSM through age 26 years. We assessed evidence of HPV among vaccine-eligible MSM and transgender women to monitor vaccine impact. METHODS: During 2012-2014, MSM aged 18-26 years at select clinics completed a computer-assisted self-interview regarding sexual behavior, human immunodeficiency virus (HIV) status, and vaccinations. Self-collected anal swab and oral rinse specimens were tested for HPV DNA (37 types) by L1 consensus polymerase chain reaction; serum was tested for HPV antibodies (4 types) by a multiplexed virus-like particle-based immunoglobulin G direct enzyme-linked immunosorbent assay. RESULTS: Among 922 vaccine-eligible participants, the mean age was 23 years, and the mean number of lifetime sex partners was 37. Among 834 without HIV infection, any anal HPV was detected in 69.4% and any oral HPV in 8.4%, yet only 8.5% had evidence of exposure to all quadrivalent vaccine types. In multivariate analysis, HPV prevalence varied significantly (P < .05) by HIV status, sexual orientation, and lifetime number of sex partners, but not by race/ethnicity. DISCUSSIONS: Most young MSM lacked evidence of current or past infection with all vaccine-type HPV types, suggesting that they could benefit from vaccination. The impact of vaccination among MSM may be assessed by monitoring HPV prevalence, including in self-collected specimens. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Gay, bisexual, and other men who have sex with men (MSM) are at high risk for humanpapillomavirus (HPV) infection; vaccination is recommended for US males, including MSM through age 26 years. We assessed evidence of HPV among vaccine-eligible MSM and transgender women to monitor vaccine impact. METHODS: During 2012-2014, MSM aged 18-26 years at select clinics completed a computer-assisted self-interview regarding sexual behavior, human immunodeficiency virus (HIV) status, and vaccinations. Self-collected anal swab and oral rinse specimens were tested for HPV DNA (37 types) by L1 consensus polymerase chain reaction; serum was tested for HPV antibodies (4 types) by a multiplexed virus-like particle-based immunoglobulin G direct enzyme-linked immunosorbent assay. RESULTS: Among 922 vaccine-eligible participants, the mean age was 23 years, and the mean number of lifetime sex partners was 37. Among 834 without HIV infection, any anal HPV was detected in 69.4% and any oral HPV in 8.4%, yet only 8.5% had evidence of exposure to all quadrivalent vaccine types. In multivariate analysis, HPV prevalence varied significantly (P < .05) by HIV status, sexual orientation, and lifetime number of sex partners, but not by race/ethnicity. DISCUSSIONS: Most young MSM lacked evidence of current or past infection with all vaccine-type HPV types, suggesting that they could benefit from vaccination. The impact of vaccination among MSM may be assessed by monitoring HPV prevalence, including in self-collected specimens. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Mark Gilbert; Michael Kwag; Wendy Mei; Claudia Rank; Rhonda Kropp; Alberto Severini; Dirk van Niekerk; Chen Zhou; Natasha Press; Gina Ogilvie; Tom Wong Journal: Sex Transm Dis Date: 2011-10 Impact factor: 2.830
Authors: Mona Saraiya; Elizabeth R Unger; Trevor D Thompson; Charles F Lynch; Brenda Y Hernandez; Christopher W Lyu; Martin Steinau; Meg Watson; Edward J Wilkinson; Claudia Hopenhayn; Glenn Copeland; Wendy Cozen; Edward S Peters; Youjie Huang; Maria Sibug Saber; Sean Altekruse; Marc T Goodman Journal: J Natl Cancer Inst Date: 2015-04-29 Impact factor: 13.506
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Sofie H Mooij; Olivia Landén; Fiona R M van der Klis; Marianne A B van der Sande; Hester E de Melker; Roel A Coutinho; Arne van Eeden; Martijn S van Rooijen; Chris J L M Meijer; Maarten F Schim van der Loeff Journal: J Infect Date: 2014-06-12 Impact factor: 6.072
Authors: Huachun Zou; Sepehr N Tabrizi; Andrew E Grulich; Suzanne M Garland; Jane S Hocking; Catriona S Bradshaw; Andrea Morrow; Garrett Prestage; Alyssa M Cornall; Christopher K Fairley; Marcus Y Chen Journal: J Infect Dis Date: 2013-11-21 Impact factor: 5.226
Authors: Perry N Halkitis; Pamela Valera; Caleb E LoSchiavo; Stephen E Goldstone; Maria Kanztanou; Anthony J Maiolatesi; Danielle C Ompad; Richard E Greene; Farzana Kapadia Journal: AIDS Patient Care STDS Date: 2019-04 Impact factor: 5.078
Authors: Emmanuel Chandler; Lili Ding; Pamina Gorbach; Eduardo L Franco; Darron A Brown; Lea E Widdice; David I Bernstein; Jessica A Kahn Journal: J Adolesc Health Date: 2018-07 Impact factor: 5.012
Authors: Elissa Meites; Rachel L Winer; Michael E Newcomb; Pamina M Gorbach; Troy D Querec; Jessica Rudd; Tom Collins; John Lin; Janell Moore; Thomas Remble; Fred Swanson; Justin Franz; Robert K Bolan; Matthew R Golden; Brian Mustanski; Richard A Crosby; Elizabeth R Unger; Lauri E Markowitz Journal: J Infect Dis Date: 2020-11-13 Impact factor: 5.226
Authors: Vidisha Singh; Beau Gratzer; Pamina M Gorbach; Richard A Crosby; Gitika Panicker; Martin Steinau; Raiza Amiling; Elizabeth R Unger; Lauri E Markowitz; Elissa Meites Journal: Sex Transm Dis Date: 2019-10 Impact factor: 2.830
Authors: Pamina M Gorbach; Ryan Cook; Beau Gratzer; Thomas Collins; Adam Parrish; Janell Moore; Peter R Kerndt; Richard A Crosby; Lauri E Markowitz; Elissa Meites Journal: Sex Transm Dis Date: 2017-07 Impact factor: 2.830
Authors: Sara E Oliver; Brooke E Hoots; Gabriela Paz-Bailey; Lauri E Markowitz; Elissa Meites Journal: J Acquir Immune Defic Syndr Date: 2017-07-01 Impact factor: 3.731
Authors: Alan G Nyitray; Kayo Fujimoto; Jing Zhao; Anna R Giuliano; John A Schneider; Lu-Yu Hwang Journal: J Infect Dis Date: 2018-02-14 Impact factor: 5.226
Authors: Annie-Laurie McRee; Abigail Shoben; Jose A Bauermeister; Mira L Katz; Electra D Paskett; Paul L Reiter Journal: Vaccine Date: 2018-01-10 Impact factor: 3.641